GE Reports

Yesterday, GE announced a significant advancement in cancer research with pharmaceutical company Eli Lilly that will allow doctors to visually map large networks of cancer cells for the first time. In the video below, Dr. Richard Gaynor, vice president of cancer research and clinical investigation at Lilly Research Laboratories, explains how it’s all about getting the right cancer drug to the right patient at the right time. “What this technology allows us to do is to understand the signatures of these different cancers so we can treat them better,” he said. “We’re going to be able to individualize therapy based on this breakthrough and that’s very, very exciting.”

While at GE’s healthymagination technology showcase, currently underway in New York City, the researchers from Lilly and GE Global Research explained that the new technology can simultaneously map more than 25 proteins in tumors at the sub-cellular level, an important step in the development of personalized cancer treatments. In the video, the multi-colored images of cells show how the technology can highlight key biomarker networks and their interaction with one another.

* Read the full announcement

Read our recent stories from the new healthymagination technology showcase:
* “Pediatric design turns scary MRIs into ‘Adventures’”
* “GE announces cancer research; $250M fund; clinic aid”
* “A closer look at GE’s pocket-sized Vscan ultrasound”
* “Vscan pocket-sized, ultra-smart ultrasound unveiled”
* “A breakthrough decision support solution for docs”
* “Tackling access with Brivo imaging technologies”
* “The business of bringing healthymagination to market”
* “At the showcase: Health by design and window tweets”
* “Scintillating tech: The world’s 1st high-def CT scanner”
* “Healthymagination tech showcase kicks off in NYC”

* Watch a replay of the October 21 webcast from the healthymagination showcase in New York.
* Check out photos from the healthymagination showcase on Flickr